REFERENCES
- National Clearinghouse for Drug Abuse Information. Fact Sheet on Naltrexone. Series 38(1), National Institute on Drug Abuse, Rockville, MD December 1978
- Martin W. R., Jasinki D. R. Clin. Pharm. Ther. 1973; 14: 142
- Taylor S., Rodgers R., Lynn R., Gerber N. J. Pharmacol. Exp. Ther. 1980; 213: 289
- Wall M. E., Brian D. R., Perez-Reyes M. Drug Metab. Disposition 1981; 9: 370
- Peh K. K., Billa N., Yuen K. H. J. Chromatogr. B 1997; 701: 140
- Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed., Marcel Dekker, New York 1982; 145
- Wagner J. G. Fundamentals of Clinical Pharmacokinetics. 1st ed., Drug Intelligence Publication, Hamilton, IL 1975; 285
- Verebey K., Volavka J., Mule S. J., Resnick R. B. Clin. Pharmacol. Ther. 1980; 20: 315
- U.S. Pharmacopoeial Convention, USP D1. Drug Information for the Health Care Professional. 14th ed, Rockville, Rockville, MD 1994; 1982
- Westlake W. J. Biopharmaceutical Statistics for Drug Development, K. E. Peace. Marcel Dekker, New York 1988; 329
- U.S. Pharmacopoeial Convention. The United States Pharmacopoeia XXXIII. Author, Rockville, MD 1995
- Diletti E., Haushcke D., Steinijans V. W. Int. J. Clin. Pharmacol. Ther. Toxicol 1991; 29: 1
- Weiner D. L. Statistics in the Pharmaceutical Industry, C. R. Buncher, J. Y. Tsay. Marcel Dekker, New York 1981; 205
- Siouf A., Sandrenan N., Godbillon J., Trunet P., Czendlik C., Howald H., Pfister Ch., Ezzet F. Biopharm. Drug Disp. 1997; 18(6)489
- Chiang C. N., Hollister L. E., Kishimoto A., Barnett G. Clin. Pharmacol. Ther. 1984; 36: 704